Abstract: Disclosed are a preparation method for a kinase inhibitor and a use thereof. The kinase inhibitor is a compound represented by formula (I) wherein the groups are defined as described in the description. The compound of formula (I) has a kinase inhibitory activity and therefore can be used for the preparation of medicines for treating kinase activity-related diseases.
Type:
Grant
Filed:
April 15, 2016
Date of Patent:
June 4, 2019
Assignee:
CHANGZHOU LONGTHERA PHARMACEUTICALS INC.